Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-Nucleotidase domain-containing protein 4 (NT5DC4) is a putative hydrolase enzyme encoded by the NT5DC4 gene. It is a member of the cytosolic 5′-nucleotidase II enzyme family, which catalyzes the intracellular hydrolysis of 5'-nucleotides. NT5DC4 contains the characteristic 5'-nucleotidase domain, suggesting a similar catalytic activity, though its specific substrate specificity, biological roles, and tissue distribution remain uncharacterized[1][2][7]. Associations with rare diseases have been noted via genetic locus overlap but there are no demonstrated direct functional disease links or therapeutic relevance at this time. Other family members (such as NT5C2) play a role in purine metabolism, but little is known about NT5DC4's physiological or pathological significance[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-Nucleotidase domain-containing protein 4 (NT5DC4).